J
Jeanne E. Poole
Researcher at University of Washington
Publications - 194
Citations - 16452
Jeanne E. Poole is an academic researcher from University of Washington. The author has contributed to research in topics: Heart failure & Implantable cardioverter-defibrillator. The author has an hindex of 45, co-authored 171 publications receiving 13920 citations. Previous affiliations of Jeanne E. Poole include University of Washington Medical Center & Duke University.
Papers
More filters
Journal ArticleDOI
Amiodarone or an implantable cardioverter-defibrillator for congestive Heart failure
Gust H. Bardy,Kerry L. Lee,Daniel B. Mark,Jeanne E. Poole,Douglas L. Packer,Robin Boineau,Michael J. Domanski,Charles Troutman,Jill Anderson,Steven McNulty,Nancy E. Clapp-Channing,Linda Davidson-Ray,Elizabeth S. Fraulo,Daniel P. Fishbein,Richard M. Luceri,John Ip +15 more
TL;DR: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.
Journal ArticleDOI
Prognostic importance of defibrillator shocks in patients with heart failure.
Jeanne E. Poole,George Johnson,Anne S. Hellkamp,Jill Anderson,David J. Callans,Merritt H. Raitt,Ramakota K. Reddy,Francis E. Marchlinski,Raymond Yee,Thomas Guarnieri,Mario Talajic,David J. Wilber,Daniel P. Fishbein,Douglas L. Packer,Daniel B. Mark,Kerry L. Lee,Gust H. Bardy +16 more
TL;DR: Among patients with heart failure in whom an ICD is implanted for primary prevention, those who receive shocks for any arrhythmia have a substantially higher risk of death than similar patients who do not receive such shocks.
Journal ArticleDOI
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial
Douglas L. Packer,Daniel B. Mark,Richard A. Robb,Kristi H. Monahan,Tristram D. Bahnson,Jeanne E. Poole,Peter A. Noseworthy,Yves Rosenberg,Neal Jeffries,L. Brent Mitchell,Greg C. Flaker,Evgeny Pokushalov,Alexander Romanov,T. Jared Bunch,Georg Noelker,Ardashev Av,Amiran Revishvili,David J. Wilber,Riccardo Cappato,Karl-Heinz Kuck,Gerhard Hindricks,D. Wyn Davies,Peter R. Kowey,Gerald V. Naccarelli,James A. Reiffel,Jonathan P. Piccini,Adam P. Silverstein,Hussein R. Al-Khalidi,Kerry L. Lee +28 more
TL;DR: Among patients with AF, the strategy of catheter ablation, compared with medical therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest, which should be considered in interpreting the results of the trial.
Journal ArticleDOI
Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures Results From the REPLACE Registry
Jeanne E. Poole,Marye J. Gleva,Theofanie Mela,Mina K. Chung,Daniel Z. Uslan,Richard Borge,Venkateshwar Gottipaty,Timothy Shinn,Dan Dan,Leon A. Feldman,Hanscy Seide,Stuart A. Winston,John J. Gallagher,Jonathan J. Langberg,Kevin Mitchell,Richard Holcomb +15 more
TL;DR: In this paper, the authors evaluated predefined procedure-related complication rates associated with elective pacemaker or implantable cardioverter-defibrillator generator replacements over 6 months of follow-up.
Journal ArticleDOI
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.
Birgit Vogel,Mónica Acevedo,Yolande Appelman,C. Noel Bairey Merz,Alaide Chieffo,Gemma A. Figtree,Mayra Guerrero,Vijay Kunadian,Vijay Kunadian,Carolyn S.P. Lam,Angela H.E.M. Maas,Anastasia S. Mihailidou,Anastasia S. Mihailidou,Anastasia S. Mihailidou,Agnieszka Olszanecka,Jeanne E. Poole,Clara Saldarriaga,Jacqueline Saw,Liesl Zühlke,Roxana Mehran +19 more
TL;DR: In this paper, the authors presented the first effort of its kind to connect stakeholders, to ignite global awareness of sex-related and gender-related disparities in cardiovascular disease, and to provide a springboard for future research.